These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 11219309

  • 41. Quinolone anti-infectives block cancer reproduction in animal tests.
    Oncology (Williston Park); 1992 Apr; 6(4):48. PubMed ID: 1316138
    [No Abstract] [Full Text] [Related]

  • 42. DNA topoisomerases.
    Osheroff N.
    Biochim Biophys Acta; 1998 Oct 01; 1400(1-3):1-2. PubMed ID: 9867354
    [No Abstract] [Full Text] [Related]

  • 43. [Current and future aspects of quinolones].
    Bush V, Dalkhoff A, Tsaĭler KhI.
    Antibiot Khimioter; 1993 Oct 01; 38(2-3):3-8. PubMed ID: 8074561
    [No Abstract] [Full Text] [Related]

  • 44. Gram-positive infections and quinolones in neutropenia.
    Altclas J, Costantini P.
    Ann Intern Med; 1997 May 15; 126(10):830; author reply 831. PubMed ID: 9148665
    [No Abstract] [Full Text] [Related]

  • 45. [On the bacteriostatic activity of acetylacetic asters].
    Soleil J, Marchal JG, Loppinet V.
    Ann Inst Pasteur (Paris); 1966 Sep 15; 111(3):373-5. PubMed ID: 5970798
    [No Abstract] [Full Text] [Related]

  • 46. [Anti-infective agents and bacterial resistance, monitor, eradicate or avoid resistance?].
    Bergogne-Bérézin E.
    Presse Med; 2002 Nov 30; 31(38):1779. PubMed ID: 12497715
    [No Abstract] [Full Text] [Related]

  • 47. Joining forces: Leveraging novel combination therapies to combat infections with eukaryotic pathogens.
    Ham RE, Temesvari LA.
    PLoS Pathog; 2020 Dec 30; 16(12):e1009081. PubMed ID: 33382854
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Update on cross-resistance of fluoroquinolones.
    Garau J.
    Int J Clin Pract Suppl; 2000 Dec 30; (115):94-8. PubMed ID: 11219309
    [No Abstract] [Full Text] [Related]

  • 50. [Where are quinolones going? New agents in development].
    Holzgrabe U.
    Pharm Unserer Zeit; 2001 Dec 30; 30(5):446-8. PubMed ID: 11575182
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. [Mechanism of action and resistance to fluoroquinolones].
    Alarcón T, López-Brea M.
    Enferm Infecc Microbiol Clin; 1996 Feb 30; 14(2):111-7. PubMed ID: 8714159
    [No Abstract] [Full Text] [Related]

  • 53. Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection.
    Ruiz J.
    J Antimicrob Chemother; 2003 May 30; 51(5):1109-17. PubMed ID: 12697644
    [Abstract] [Full Text] [Related]

  • 54. Update on cross-resistance of fluoroquinolones.
    Garau J.
    Int J Clin Pract Suppl; 2000 Dec 30; (115):94-8. PubMed ID: 11219309
    [No Abstract] [Full Text] [Related]

  • 55. [Where are quinolones going? New agents in development].
    Holzgrabe U.
    Pharm Unserer Zeit; 2001 Dec 30; 30(5):446-8. PubMed ID: 11575182
    [No Abstract] [Full Text] [Related]

  • 56. Quinolone resistance in Staphylococci: activities of new nonfluorinated quinolones against molecular targets in whole cells and clinical isolates.
    Roychoudhury S, Catrenich CE, McIntosh EJ, McKeever HD, Makin KM, Koenigs PM, Ledoussal B.
    Antimicrob Agents Chemother; 2001 Apr 30; 45(4):1115-20. PubMed ID: 11257024
    [Abstract] [Full Text] [Related]

  • 57. [Mechanism of action and resistance to fluoroquinolones].
    Alarcón T, López-Brea M.
    Enferm Infecc Microbiol Clin; 1996 Feb 30; 14(2):111-7. PubMed ID: 8714159
    [No Abstract] [Full Text] [Related]

  • 58. Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection.
    Ruiz J.
    J Antimicrob Chemother; 2003 May 30; 51(5):1109-17. PubMed ID: 12697644
    [Abstract] [Full Text] [Related]

  • 59. Update on cross-resistance of fluoroquinolones.
    Garau J.
    Int J Clin Pract Suppl; 2000 Dec 30; (115):94-8. PubMed ID: 11219309
    [No Abstract] [Full Text] [Related]

  • 60. [Where are quinolones going? New agents in development].
    Holzgrabe U.
    Pharm Unserer Zeit; 2001 Dec 30; 30(5):446-8. PubMed ID: 11575182
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.